FLY vs REGN · rev $30.8M vs P/E 14, rev $14.34B
Firefly Aerospace Inc. Common Stock (FLY) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Firefly Aerospace Inc. Common Stock (FLY) is a aerospace & defense company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported FLY revenue for 2025-09-30 was $30.8M. Net income was -$257.3M. Revenue was up 97.9% from 2025-06-30 to 2025-09-30. FLY currently screens at market cap $4.84B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
FLY currently screens at market cap $4.84B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the FLY and REGN stock pages for the full models.
Not investment advice.